SHH and cancer: Recently, ligand-dependent activation of the Hh pathway, especially due to an aberrant expression of Shh, has been detected in various cancers including gastric cancer (Berman et al, 2003; Watkins et al, 2003; Karhadkar et al, 2004; Sanchez et al, 2004; Sheng et al, 2004).